| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.06 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.086 | 0.06 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.06 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.096 | 0.07 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.37 | 0.07 |